Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Cash from Investing Activities: 2010-2025

Historic Cash from Investing Activities for Ironwood Pharmaceuticals (IRWD) over the last 14 years, with Sep 2025 value amounting to -$2,000.

  • Ironwood Pharmaceuticals' Cash from Investing Activities rose 87.50% to -$2,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$51,000, marking a year-over-year increase of 98.82%. This contributed to the annual value of -$142,000 for FY2024, which is 99.99% up from last year.
  • Latest data reveals that Ironwood Pharmaceuticals reported Cash from Investing Activities of -$2,000 as of Q3 2025, which was down 0.00% from -$2,000 recorded in Q2 2025.
  • Ironwood Pharmaceuticals' Cash from Investing Activities' 5-year high stood at $27,000 during Q4 2022, with a 5-year trough of -$999.5 million in Q2 2023.
  • For the 3-year period, Ironwood Pharmaceuticals' Cash from Investing Activities averaged around -$102.6 million, with its median value being -$44,500 (2024).
  • In the last 5 years, Ironwood Pharmaceuticals' Cash from Investing Activities surged by 121.09% in 2022 and then plummeted by 1,135,686.36% in 2023.
  • Quarterly analysis of 5 years shows Ironwood Pharmaceuticals' Cash from Investing Activities stood at -$128,000 in 2021, then skyrocketed by 121.09% to $27,000 in 2022, then tumbled by 15,611.11% to -$4.2 million in 2023, then spiked by 99.93% to -$16,000 in 2024, then soared by 87.50% to -$2,000 in 2025.
  • Its last three reported values are -$2,000 in Q3 2025, -$2,000 for Q2 2025, and -$31,000 during Q1 2025.